A Look Into Energy Sector Value Stocks
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices…
Dow Rises 50 Points; Quoin Pharmaceuticals Shares Plunge
U.S. stocks traded slightly higher toward the end of trading following the release of Fed minutes.
The Dow traded up 0.15% to 33,180.87 while the NASDAQ rose 0.49% to 11,548.73. The S&P 500 also rose, gaining, 0.33% to 4,010.53.
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous Formulation For The Treatment Of Acute Heart Failure."
Wingstop, La-Z-Boy, Palo Alto Networks And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded slightly lower, with the Dow Jones dropping around 10 points on Wednesday. Here are some big stocks recording gains in today’s session.
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell
• Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.
Reported Late Tuesday, Berry Corporation Announces Management Succession Plan Effective January 1; Trem Smith, Current Board Chairman, President And CEO, To Become Executive Chairman; Fernando Araujo To Become CEO; Mike Helm To Become CFO; Cary Baetz C…
Berry Corporation (bry) (NASDAQ:BRY) today announced the evolution of its executive team, effective January 1, 2023:
Piper Sandler Maintains Overweight on Berry (bry), Lowers Price Target to $11
Piper Sandler analyst Mark Lear maintains Berry (bry) (NASDAQ:BRY) with a Overweight and lowers the price target from $12 to $11.
Tilray Brands, Canopy Growth, Cronos Group And Other Big Gainers From Thursday
U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Thursday. Here is the list of some big stocks recording gains in the previous session.
Piper Sandler Maintains Overweight on Berry (bry), Lowers Price Target to $12
Piper Sandler analyst Mark Lear maintains Berry (bry) (NASDAQ:BRY) with a Overweight and lowers the price target from $15 to $12.